Loading chat...

NY A10193

Bill

Status

Introduced

5/10/2024

Primary Sponsor

Keith Brown

Click for details

Origin

Assembly

2023-2024 General Assembly

AI Summary

  • Expands the state definition of "opioid antagonist" to include all FDA-approved forms and doses of Naloxone, rather than limiting it to naloxone and medications approved by the department.

  • Requires the Department of Health to make available all forms and dosages of Naloxone approved by the FDA for opioid antagonist purposes.

  • Mandates that any purchase, distribution, or authorization to prescribe opioid antagonists must allow for choice of any FDA-approved formulation or dosage made available by the department.

  • Updates references to naloxone in the Education Law to reference "opioid antagonist" as defined under Public Health Law, allowing advanced home health aides to administer pre-filled auto-injections of any approved opioid antagonist.

  • Takes effect 30 days after becoming law; authorizes the Department of Health to adopt necessary rules and regulations immediately upon enactment.

Legislative Description

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.

Last Action

enacting clause stricken

9/6/2024

Committee Referrals

Health5/10/2024

Full Bill Text

No bill text available